Exploring Knowledge of Antibiotic Use, Resistance, and Stewardship Programs among Pharmacy Technicians Serving in Ambulatory Care Settings in Pakistan and the Implications.
Pakistan
ambulatory healthcare
antimicrobial resistance
antimicrobial stewardship programs
antimicrobials
awareness
pharmacy technicians
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
08 Jul 2022
08 Jul 2022
Historique:
received:
13
06
2022
revised:
28
06
2022
accepted:
04
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
Antimicrobial resistance (AMR) is a leading global health threat, increasing morbidity, mortality, and costs, with excessive and irrational use of antimicrobials contributing to the development of AMR. Consequently, the aims of this study were to evaluate the understanding of antibiotic use, AMR, and antimicrobial stewardship programs (ASPs) among pharmacy technicians serving in ambulatory healthcare settings in Pakistan. A cross-sectional survey was conducted among pharmacy technicians serving in 144 ambulatory care settings in seven districts of Punjab province using a validated questionnaire. Overall, 376 technicians completed the survey (85.8% response rate). The majority were men (89.1%), aged 25−35 years (45.1%), serving in emergency departments (43.9%) and filling 31−60 prescriptions per day (37.5%). Most (79.5%) knew that antibiotics were one of the most frequently prescribed drug classes, while 59.8% believed antibiotics for common colds did not speed up recovery. Inadequate duration (59.6%) and inadequate dosages (57.7%) of antibiotic therapy were reported as the leading causes of AMR. Terms including ‘superbugs’, ‘multidrug resistance’, and ‘extensively drug resistance’ were known to 42.0%, 25.3%, and 20.7% of participants, respectively; however, <10% knew about ASPs, including their core elements and purpose. Our study revealed that pharmacy technicians have adequate awareness of antibiotic use but are currently unaware of AMR and ASPs, which is a concern.
Identifiants
pubmed: 35884175
pii: antibiotics11070921
doi: 10.3390/antibiotics11070921
pmc: PMC9311796
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Jundishapur J Microbiol. 2015 Jul 25;8(7):e19272
pubmed: 26421129
Lancet Infect Dis. 2019 Mar;19(3):242-243
pubmed: 30833059
Curr Med Res Opin. 2020 Feb;36(2):301-327
pubmed: 31794332
Heliyon. 2019 Jul 25;5(7):e02159
pubmed: 31384689
PLoS One. 2017 Jul 10;12(7):e0180799
pubmed: 28700631
BMC Infect Dis. 2018 May 8;18(1):209
pubmed: 29739360
Int J Clin Pharm. 2020 Aug;42(4):1227-1236
pubmed: 32458227
Antimicrob Resist Infect Control. 2017 May 15;6:47
pubmed: 28515903
Lancet. 2020 Oct 24;396(10259):1345-1352
pubmed: 33031764
Res Social Adm Pharm. 2021 Jan;17(1):1964-1966
pubmed: 32317154
Antibiotics (Basel). 2022 Mar 25;11(4):
pubmed: 35453198
Glob J Health Sci. 2015 Jun 25;8(2):190-7
pubmed: 26383222
Life (Basel). 2021 Jun 07;11(6):
pubmed: 34200116
PLoS One. 2019 Oct 3;14(10):e0223409
pubmed: 31581222
BMC Infect Dis. 2021 Apr 21;21(1):374
pubmed: 33882843
Int J Environ Res Public Health. 2019 May 05;16(9):
pubmed: 31060262
BMJ. 2020 Oct 19;371:m4057
pubmed: 33077424
Pharm Pract (Granada). 2015 Jan-Mar;13(1):523
pubmed: 25883690
Infect Drug Resist. 2021 Mar 22;14:1129-1140
pubmed: 33790584
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
BMC Res Notes. 2019 Sep 18;12(1):601
pubmed: 31533802
PLoS One. 2017 Dec 21;12(12):e0189621
pubmed: 29267306
Int J Gen Med. 2021 Feb 18;14:515-530
pubmed: 33633461
PLoS One. 2022 Feb 17;17(2):e0263756
pubmed: 35176043
Am J Trop Med Hyg. 2020 Jun;102(6):1184-1188
pubmed: 32323646
Euro Surveill. 2021 Mar;26(12):
pubmed: 33769250
Antimicrob Resist Infect Control. 2019 Feb 12;8:35
pubmed: 30805182
Expert Rev Clin Pharmacol. 2021 Jan;14(1):95-103
pubmed: 33252992
BMC Fam Pract. 2012 Mar 28;13:27
pubmed: 22455482
Rev Soc Bras Med Trop. 2016 May-Jun;49(3):300-4
pubmed: 27384826
Expert Rev Anti Infect Ther. 2022 Jan;20(1):71-93
pubmed: 34038294
Infect Control Hosp Epidemiol. 2021 Jun;42(6):715-721
pubmed: 33183399
J Infect Public Health. 2020 Jan;13(1):118-124
pubmed: 31548165
BMC Infect Dis. 2016 Sep 02;16:465
pubmed: 27590053
Res Social Adm Pharm. 2020 Jun;16(6):805-811
pubmed: 31501016
N Engl J Med. 2020 Nov 19;383(21):2030-2040
pubmed: 33031652
JAC Antimicrob Resist. 2020 Oct 05;2(3):dlaa070
pubmed: 34223026
J Infect Dev Ctries. 2014 Aug 13;8(8):981-6
pubmed: 25116662
J Glob Antimicrob Resist. 2019 Jun;17:132-136
pubmed: 30557686
Front Public Health. 2020 Dec 14;8:585832
pubmed: 33381485
J Res Pharm Pract. 2017 Apr-Jun;6(2):120-125
pubmed: 28616436
J Glob Antimicrob Resist. 2018 Jun;13:240-245
pubmed: 29414723
Expert Rev Anti Infect Ther. 2019 Aug;17(8):661-669
pubmed: 31335228
Nat Rev Microbiol. 2019 Jan;17(1):3
pubmed: 30467331
Res Social Adm Pharm. 2021 Jan;17(1):2032-2035
pubmed: 32245691
J Infect. 2021 Sep;83(3):e12-e13
pubmed: 34329675
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
Expert Rev Anti Infect Ther. 2015 May;13(5):665-80
pubmed: 25813839
J Res Pharm Pract. 2021 May 13;10(1):17-22
pubmed: 34295848
Antibiotics (Basel). 2021 Jan 12;10(1):
pubmed: 33445511
Front Pharmacol. 2022 Mar 08;13:771083
pubmed: 35350757
Front Pharmacol. 2020 Jan 10;10:1520
pubmed: 31998124
J Chemother. 2019 Nov - Dec;31(7-8):378-387
pubmed: 31145043
J Res Pharm Pract. 2018 Apr-Jun;7(2):77-82
pubmed: 30050960
Lancet Infect Dis. 2018 Oct;18(10):1066-1067
pubmed: 30303099
Front Pharmacol. 2021 Nov 08;12:754000
pubmed: 34819859
Antibiotics (Basel). 2019 Dec 20;9(1):
pubmed: 31861923